Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.
Publication
, Conference
Richardson, P; Soiffer, RJ; Antin, JH; Jin, Z; Kurtzberg, J; Martin, PL; Steinbach, G; Murray, KF; Vogelsang, GB; Chen, A; Krishnan, A ...
Published in: BLOOD
November 16, 2006
Duke Scholars
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2006
Volume
108
Issue
11
Start / End Page
17A / 18A
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
48th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Richardson, P., Soiffer, R. J., Antin, J. H., Jin, Z., Kurtzberg, J., Martin, P. L., … Guinan, E. C. (2006). Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial. In BLOOD (Vol. 108, pp. 17A-18A). Orlando, FL: AMER SOC HEMATOLOGY.
Richardson, Paul, R. J. Soiffer, J. H. Antin, Z. Jin, J. Kurtzberg, P. L. Martin, G. Steinbach, et al. “Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.” In BLOOD, 108:17A-18A. AMER SOC HEMATOLOGY, 2006.
Richardson P, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL, et al. Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial. In: BLOOD. AMER SOC HEMATOLOGY; 2006. p. 17A-18A.
Richardson, Paul, et al. “Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial.” BLOOD, vol. 108, no. 11, AMER SOC HEMATOLOGY, 2006, pp. 17A-18A.
Richardson P, Soiffer RJ, Antin JH, Jin Z, Kurtzberg J, Martin PL, Steinbach G, Murray KF, Vogelsang GB, Chen A, Krishnan A, Kernan NA, Avigan D, Spitzer TR, Warren D, Revta C, Wei LJ, Iacobelli M, McDonald GB, Guinan EC. Defibrotide (DF) for the treatment of severe veno-occlusive disease (sVOD) and multi-organ failure (MOF) post SCT: Final results of a multi-center, randomized, dose-finding trial. BLOOD. AMER SOC HEMATOLOGY; 2006. p. 17A-18A.
Published In
BLOOD
ISSN
0006-4971
Publication Date
November 16, 2006
Volume
108
Issue
11
Start / End Page
17A / 18A
Location
Orlando, FL
Publisher
AMER SOC HEMATOLOGY
Conference Name
48th Annual Meeting of the American-Society-of-Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology